These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8173232)
1. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity. Yanagihara K; Seyama T; Watanabe Y Nat Immun; 1994; 13(2-3):102-12. PubMed ID: 8173232 [TBL] [Abstract][Full Text] [Related]
2. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955 [TBL] [Abstract][Full Text] [Related]
3. [Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene]. Hashimura T; Hiura M; Yoshida O; Teramura Y; Kuribayashi K; Watanabe Y Hinyokika Kiyo; 1993 Dec; 39(12):1205-8. PubMed ID: 8285171 [TBL] [Abstract][Full Text] [Related]
4. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2. Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064 [TBL] [Abstract][Full Text] [Related]
5. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988 [TBL] [Abstract][Full Text] [Related]
6. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma. Shiau AL; Lin CY; Tzai TS; Wu CL Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496 [TBL] [Abstract][Full Text] [Related]
7. [Gene therapy by in vivo interferon-gamma gene transfer to murine bladder tumor]. Hashimura T; Ueda T; Hiura M; Yoshida O; Kawabata K; Watanabe Y; Takami M Hinyokika Kiyo; 1997 Nov; 43(11):809-13. PubMed ID: 9436027 [TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models. Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R; Yoneda Y; Kuriyama M; Kubota T J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111 [TBL] [Abstract][Full Text] [Related]
10. [A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer]. Nishihara K Nihon Geka Hokan; 1989 Jan; 58(1):18-42. PubMed ID: 2508589 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432 [TBL] [Abstract][Full Text] [Related]
12. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012 [TBL] [Abstract][Full Text] [Related]
14. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma. Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG Cancer Gene Ther; 1999; 6(2):147-54. PubMed ID: 10195881 [TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Pulaski BA; Smyth MJ; Ostrand-Rosenberg S Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047 [TBL] [Abstract][Full Text] [Related]
16. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice. Morikawa K; Fan D; Denkins YM; Levin B; Gutterman JU; Walker SM; Fidler IJ Cancer Res; 1989 Feb; 49(4):799-805. PubMed ID: 2492206 [TBL] [Abstract][Full Text] [Related]
19. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816 [TBL] [Abstract][Full Text] [Related]
20. Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase. Wang B; Xiong Q; Shi Q; Le X; Xie K Oncogene; 2001 Oct; 20(47):6930-7. PubMed ID: 11687972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]